Brief: Pivot Pharma Develops Transdermal Patch for Delivery of CBD and THC
15/02/2019 09:23
Feb 15 (Reuters) - Pivot Pharmaceuticals Inc PVOT.CD :
* PIVOT PHARMACEUTICALS - HAS COMPLETED DEVELOPMENT OF A
CONTROLLED-RELEASE TRANSDERMAL PATCH SYSTEM FOR DELIVERY OF
CANNABINOIDS
Source text for Eikon: ID:nCNWDPz4Ca
Further company coverage: PVOT.CD
((Reuters.Briefs@thomsonreuters.com;))
Recent news on BetterLife Pharma
See all newsBrief: Betterlife Pharma Provides Scientific Update On Neuroplastogenic Activity Of BETR-001
Brief: Betterlife Pharma Advanced In IND-enabling Studies For BETR-001
Brief: BetterLife Announces Closing Of $1.168 Million Convertible Debentures To Further Advance IND-Enabling Studies Of Its Non-Hallucinogenic LSD-Based Drug Candidate BETR-001
Brief: Omineca Announces $2 Mln Brokered Financing Of Flow-Through Units
Brief: Betterlife Announces Pricing Of Proposed Offering Of Units